| scholarly article | Q13442814 |
| P50 | author | Robert V. Tauxe | Q7350556 |
| Timothy M. Uyeki | Q84362200 | ||
| P2093 | author name string | William A Fischer | |
| P2860 | cites work | A case of severe Ebola virus infection complicated by gram-negative septicemia | Q39148299 |
| Announcement: Interim U.S. guidance for monitoring and movement of persons with potential Ebola virus exposure | Q40177522 | ||
| Clinical care of two patients with Ebola virus disease in the United States | Q40183261 | ||
| Clinical presentation of patients with Ebola virus disease in Conakry, Guinea | Q40184101 | ||
| Protecting health care workers from Ebola: personal protective equipment is critical but is not enough | Q40195311 | ||
| Persistence in darkness of virulent alphaviruses, Ebola virus, and Lassa virus deposited on solid surfaces | Q40348606 | ||
| Ebola hemorrhagic fever: evaluation of passive immunotherapy in nonhuman primates | Q40433072 | ||
| Persistence and genetic stability of Ebola virus during the outbreak in Kikwit, Democratic Republic of the Congo, 1995. | Q44089744 | ||
| Evaluation of immune globulin and recombinant interferon-alpha2b for treatment of experimental Ebola virus infections | Q44089771 | ||
| US signs contract with ZMapp maker to accelerate development of the Ebola drug | Q44093344 | ||
| Ebola haemorrhagic fever in Sudan, 1976. Report of a WHO/International Study Team | Q56975714 | ||
| Clinical management of filovirus-infected patients | Q22305518 | ||
| Ebola haemorrhagic fever | Q24629338 | ||
| Emergence of Zaire Ebola Virus Disease in Guinea | Q25197990 | ||
| Ebola virus disease in West Africa--the first 9 months of the epidemic and forward projections | Q28248431 | ||
| Postexposure protection of non-human primates against a lethal Ebola virus challenge with RNA interference: a proof-of-concept study | Q34022606 | ||
| Successful treatment of advanced Ebola virus infection with T-705 (favipiravir) in a small animal model | Q34040021 | ||
| Ebola hemorrhagic fever in Kikwit, Democratic Republic of the Congo: clinical observations in 103 patients | Q34068488 | ||
| The reemergence of Ebola hemorrhagic fever, Democratic Republic of the Congo, 1995. Commission de Lutte contre les Epidémies à Kikwit | Q34068497 | ||
| Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp | Q34426585 | ||
| Treatment of Ebola hemorrhagic fever with blood transfusions from convalescent patients. International Scientific and Technical Committee | Q34492427 | ||
| Preparation and use of hyperimmune serum for prophylaxis and therapy of Ebola virus infections | Q34492457 | ||
| Clinical illness and outcomes in patients with Ebola in Sierra Leone | Q35053891 | ||
| Ebola haemorrhagic fever among hospitalised children and adolescents in northern Uganda: epidemiologic and clinical observations | Q36276137 | ||
| Ebola and Marburg viruses: pathogenesis and development of countermeasures | Q36352316 | ||
| Drug targets in infections with Ebola and Marburg viruses | Q37411610 | ||
| Filovirus hemorrhagic fever outbreak case management: a review of current and future treatment options | Q37944238 | ||
| Caring for critically ill patients with ebola virus disease. Perspectives from West Africa. | Q38244204 | ||
| Organization of patient care during the Ebola hemorrhagic fever epidemic in Kikwit, Democratic Republic of the Congo, 1995. | Q39036032 | ||
| Estimating the future number of cases in the Ebola epidemic--Liberia and Sierra Leone, 2014-2015. | Q39123446 | ||
| P433 | issue | 8 | |
| P921 | main subject | Ebola hemorrhagic fever | Q51993 |
| Orthoebolavirus zairense | Q10538943 | ||
| P304 | page(s) | 788-793 | |
| P577 | publication date | 2015-06-24 | |
| P1433 | published in | American Journal of Infection Control | Q15767042 |
| P1476 | title | Ebola virus disease: What clinicians in the United States need to know | |
| P478 | volume | 43 |
| Q40052935 | Assessment of Healthcare Worker Protocol Deviations and Self-Contamination During Personal Protective Equipment Donning and Doffing |
| Q92486964 | Association between treatment with oral third-generation cephalosporin antibiotics and mortality outcomes in Ebola virus disease: a multinational retrospective cohort study |
| Q44106308 | CDC Safety Training Course for Ebola Virus Disease Healthcare Workers |
| Q40107887 | Emerging infectious diseases: Focus on infection control issues for novel coronaviruses (Severe Acute Respiratory Syndrome-CoV and Middle East Respiratory Syndrome-CoV), hemorrhagic fever viruses (Lassa and Ebola), and highly pathogenic avian influe |
| Q39229493 | Neurological Complications and Sequelae of Ebola Virus Disease |
| Q28385386 | Neurological Complications of Ebola Virus Infection |
| Q64359214 | New and emerging infectious diseases (Ebola, Middle Eastern respiratory syndrome coronavirus, carbapenem-resistant Enterobacteriaceae, Candida auris): Focus on environmental survival and germicide susceptibility |
| Q33750395 | Reflections on the Ebola Public Health Emergency of International Concern, Part 1: Post-Ebola Syndrome: The Silent Outbreak |
| Q38655105 | The natural history of acute Ebola Virus Disease among patients managed in five Ebola treatment units in West Africa: A retrospective cohort study |
Search more.